ArticleMedComm2023

Tumor-derived Vimentin as a novel biomarker for distinct subtypes predicting adjuvant chemotherapy resistance and T-cell-inflamed phenotype in small cell lung cancer.

Chaoqiang Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.